Summary Recombinant human interferon alpha inhibits growth of a human colon cancer cell line, Colo 205. To explore the mechanisms of IFN induced growth inhibition, quiescent Colo 205 cells were stimulated to proliferate in serum-free media by defined growth factors. Addition of insulin, transferrin and selenium (ITS) stimulated DNA synthesis, as measured by 3H-thymidine incorporation, in a dose-dependent manner. IFN-a (at concentrations > 100 U ml-1) inhibited ITS stimulated DNA synthesis by 63% al., 1981, 1985a). EGF-stimulated thymidine incorporation by human fibroblasts is also inhibited more than 80% by human IFN (Lin et al., 1980) . Maximum inhibition of thymidine incorporation is observed when cells are treated with IFN prior to onset of DNA synthesis. Tominaga and Lengyel (1984) and Olezak and Inglot (1980) similarly observed that treatment of quiescent BALB/c 3T3 cells with IFN inhibits cell replication induced by platelet-derived growth factor (PDGF). In a somewhat analogous system, Heyns et al. (1985) showed recombinant IFN inhibits smooth muscle cell growth induced by serum or platelet-poor plasma and PDGF. B-cell growth factor induced proliferation of hairy cell leukaemia cells is also inhibited by IFN (Paganelli et al., 1986). These studies suggest IFNs may control cell growth by acting as mitogen antagonists.
Summary Recombinant human interferon alpha inhibits growth of a human colon cancer cell line, Colo 205. To explore the mechanisms of IFN induced growth inhibition, quiescent Colo 205 cells were stimulated to proliferate in serum-free media by defined growth factors. Addition of insulin, transferrin and selenium (ITS) stimulated DNA synthesis, as measured by 3H-thymidine incorporation, in a dose-dependent manner. IFN-a (at concentrations > 100 U ml-1) inhibited ITS stimulated DNA synthesis by 63%. Inhibition of cell cycle traverse was confirmed by flow cytometric analysis. Although IFN inhibited growth of ITS-treated cells, steady state levels of c-myc mRNA remained above levels observed in unstimulated cells. IFN inhibited DNA synthesis only when added prior to mitogen stimulation. IFN, added 6 h after exposure of quiescent cells to ITS, failed to inhibit cell growth. Addition of increasing concentrations of ITS failed to overcome the IFNinduced growth inhibition. These results suggest IFN may inhibit cell growth in part by antagonizing the action of growth factors.
In addition to their antiviral activity, IFNs inhibit growth of both normal and transformed cells. However, the mechanisms of IFN mediated growth inhibition are not fully understood (Clemens & McMurlan, 1985) . One hypothesis to explain the antiproliferative activity of IFNs suggests that they act, in part, as mitogen antagonists. IFN, added sinfjltaneously with mitogens, inhibits stimulation of DNA synthesis and cell division. For example, the administration of IFN concomitant with serum blocks passage out of Go/ G1 of BALB/c 3T3 fibroblasts (Lin et al., 1986) . When quiescent 3T3 cells are stimulated to initiate DNA synthesis by epidermal growth factor (EGF) and insulin, IFN potently inhibits DNA synthesis (Taylor-Papadimtriou et al., 1981 , 1985a . EGF-stimulated thymidine incorporation by human fibroblasts is also inhibited more than 80% by human IFN (Lin et al., 1980) . Maximum inhibition of thymidine incorporation is observed when cells are treated with IFN prior to onset of DNA synthesis. Tominaga and Lengyel (1984) and Olezak and Inglot (1980) similarly observed that treatment of quiescent BALB/c 3T3 cells with IFN inhibits cell replication induced by platelet-derived growth factor (PDGF). In a somewhat analogous system, Heyns et al. (1985) showed recombinant IFN inhibits smooth muscle cell growth induced by serum or platelet-poor plasma and PDGF. B-cell growth factor induced proliferation of hairy cell leukaemia cells is also inhibited by IFN (Paganelli et al., 1986) . These studies suggest IFNs may control cell growth by acting as mitogen antagonists.
Some IFNs may be classified as naturally produced growth inhibitors. Hematopoietic cells induced to differentiate produce IFN,B which slows their own growth (Resnitsky et al., 1986) . PDGF-stimulated 3T3 fibroblasts produce IFN 18h after c-myc activation as part of a natural process of feedback inhibition (Zullo et al., 1986) . Tumour necrosis factor (TNF) (mitogenic for human diploid fibroblasts) induces cellular synthesis of ,B-IFN mRNA (Kohase et al., 1986) . Anti fl-IFN antibody enhances the mitogenic effect of TNF on confluent serum-starved fibroblasts. All of the above observations are consistent with the assumption that the induction of IFN by growth factors is a physiological negative feedback mechanism involved in control of cell proliferation.
IFN inhibits the in vitro growth of both malignant cell lines and cells derived from patient biopsies (Clemens & McMurlan, 1985) . IFN decreases clonal growth of human colon tumour cells, isolated directly from patients, in soft agar (Scheitauer et al., 1985 growth of several human colon cancer cell lines is inhibited by both naturally produced and recombinant IFNs (Denz et al., 1985) . The Colo 205 cell line, derived from a patient with adenocarcinoma of the colon, is sensitive to the antiproliferative effect of IFNax (Brouty-Boye et al., 1985) . IFN the indicated concentrations. After incubation at 37°C for 48 h, insulin (5 Mg ml-1), transferrin (5 ug ml-1) and selenium (5 ng ml-1) (ITS) were added. Sixteen hours later, the monolayers were pulsed for 60 min with 1 pCi of methyl3H-thymidine [6.7 pCi mmol -1, New England Nuclear (Boston, MA)] ml-1 of medium and incorporation into acid precipitable material determined as described (Shipley et al., 1984) . Results shown are the averages of 4 wells/point.
Assay for cell cycle distribution
The relative numbers of cells in different phases of the cell cycle were assessed by flow cytometry using propidium iodide stained nuclei (Krishan, 1975) . Cells were trypsinized and centrifuged to yield a cell pellet. Cells (2 x 106) were resuspended in 2 ml of a hyposmotic propidium iodide (0.5mgml-1) (Sigma) solution and stored refrigerated, and protected from light, until flow cytometric analysis. Both the fluorescence and narrow angle light scatter were simultaneously measured using a multiparameter fluorescence activated cell sorter (FACS IV Becton-Dickinson). Incident light at 488 nm was provided by an argon ion laser (Model 164-5 Spectra Physics) operated at 0.3 W in the light stabilized mode.
Detection of c-myc mRNA Colo 205 cells, cultured in RPMI 1640 and 10% FBS, were seeded into T75 flasks at 1 x I05 cells ml '. After incubation at 37°C for 3 days, the confluent monolayers were washed twice with RPMI 1640 without serum and further incubated with RPMI 1640 and 0.5% FBS with or without 1,000 U ml-1 of IFNax at 37°C. After 48 h, half the cultures were supplemented with ITS and 2 h later, the cells were harvested and total cytoplasmic RNA was isolated by the guanidium thiocyanate method (Chirgwin et al., 1980) . The RNA samples were dot blotted at different concentrations onto nitrocellulose filters. The filters were prehybridized for 48 h under agitation at 42°C in 5 x SSC -50 mM sodium phosphate containing 50% deionized formamide, 0.2% SDS, 0.5 mM EDTA, 5 x Denhardt's and denatured salmon sperm DNA (100 pgml-1). The blots were hybridized to a c-DNA probe nick translated to 5 x 107 cpmnpg-1 DNA with aX32P-dCTP (New England Nuclear). A 1.5 kb Clal-Eco RI DNA fragment encoding the third exon of the human c-myc gene was used. (Della-Favera et al., 1985) . Filters were hybridized 16 h at 40°C and washed at 65°C in 2 x SSC, 0.1% SDS. The filters were autoradiographed on X-ray film at -70°C using intensifying screens. Autoradiograms were quantitated by densitometric scanning using a Helena densitometer. Interferon (Units ml -') (Table II) . Confluent Colo 205 cells were exposed to medium containing 0.5% serum (control). Interferon (IFN) (1,000 Uml-1) were added to half the flasks for 48 h. Half the flasks in each of the two groups were then exposed to insulin, transferrin and selenium as described (ITS or ITS + IFN). Total RNA was isolated 2 h later. RNA (2 pg) was dot blotted onto nitrocellulose and hybridized to a 32P labelled c-myc probe. The resulting autoradiogram was quantitated by densitometry. Area integrals of these profiles were calculated relative to the level in control cells.
Effect of time of addition of IFN to quiescent Colo 205 cells To determine optimal timing of the IFN treatment, cells were exposed to IFN either before or after addition of ITS at the times indicated ( Figure 5 ). The growth inhibition observed was compared to that obtained by treating cells with IFN for 48 h prior to addition of ITS. IFNa2, added simultaneously with ITS (Time 0), inhibited growth only 50% as well as IFN added for the entire 48 h pretreatment period. IFN added 6 h after addition of ITS failed to inhibit thymidine incorporation. We also varied the length of time of IFN pretreatment. Thymidine incorporation was not as effectively inhibited when cells were pretreated with IFN for only 6 h ( Figure 5 ).
Effect of increasing concentrations of ITS on IFN mediated growth inhibition To determine if increasing concentrations of ITS could overcome the IFN mediated inhibition of cell growth, quiescent Colo cells were stimulated to proliferate by adding increasing concentrations of ITS in the presence or absence of 1,000 units of IFN. The results in Figure 6 indicate that the degree of inhibition of thymidine incorporation was inversely related to the concentration of mitogens. The inhibitory effect of IFN could not be overcome by increasing the concentration of the mitogenic stimulus. Concentrations of ITS 10 times the maximal stimulatory concentration failed to overcome the IFN-induced inhibition of thymidine incorporation. (Lin et al., 1986) , EGF and insulin (Lin et al., 1980; Taylor-Papadimitriou et al., 1981) , or PDGF (Tominaga & Lengyel, 1984) blocks GO/G1-S passage of human and murine fibroblasts. Similarly, growth factor stimulated proliferation of smooth muscle cells (Heyns et al., 1985) , or leukaemic cells (Paganelli et al., 1986) (Jasny et al., 1985) . It is therefore possible that continuous occupancy of the IFN receptor by exogenous ligand resulted in stabilization of the tubulin network, ultimately inhibiting DNA synthesis induced by growth factors. Taylor-Papadimitriou et al. (1985a) have found that tubulin disrupting agents such as colchicine or nocodazole are very effective at reversing the inhibitory effect of IFN on DNA synthesis.
As expected, exposure of quiescent cells to ITS increased c-myc mRNA levels. Although IFN prevented ITSstimulated thymidine incorporation into DNA, IFN failed to decrease c-myc RNA levels down to those observed in unstimulated cells. Tominaga and Lengyel (1984) similarly reported IFN pretreatment of 3T3 cells for 48 hours did not inhibit the ability of PDGF to increase levels of c-myc mRNA. Einat et al. (1985) found that IFN inhibited growth of HL-60 cells, but failed to reduce steady state levels of cmyc mRNA. In contrast, IFN-a produced a decrease of cmyc mRNA levels and caused G1/Go arrest of Daudi lymphoma cells. In addition we observed increased levels of c-myc mRNA in cells treated with IFN alone. Tominaga and Lengyel (1984) found IFN pretreatment of 3T3 cells subsequently exposed to PDGF, resulted in higher levels of c-myc mRNA than in cells treated with PDGF only. In contrast to our study, IFN alone did not increase levels of c-myc mRNA. The mechanism of this IFN-mediated increase in cmyc mRNA levels is not known. Tominaga and Lengyel (1984) suggested that the increase may reflect an IFNmediated inhibition of labile repressor proteins that regulate steady state levels of c-myc mRNA. It is known that IFN differentially regulates protein synthesis. Thus, the increase in levels of c-myc mRNA in cells treated with IFN may be a consequence of an impairment of synthesis of these repressor proteins. Thus, IFN blocked thymidine incorporation induced by ITS, but did not prevent an increase in c-myc mRNA levels. These findings suggest expression of the c-myc oncogene may be a primary consequence of growth factor receptor interaction, rather than a cause or consequence of cell proliferation.
Our results indicated addition of IFN 6h after administration of insulin failed to inhibit cell growth. Lin et al. (1986) similarly demonstrated that addition of IFN 6h after serum stimulation of 3T3 fibroblasts failed to inhibit cell growth. In contrast, Lin et al. (1980) earlier found that IFN rapidly blocks increases in thymidine incorporation even after entry of human fibroblasts into S phase.
The inhibitory effect of IFN on Colo cultures could not be overcome by high concentrations of ITS. The addition of supramaximal concentrations of ITS (10 times the dose required to elicit maximal proliferation) failed to prevent the IFN-induced inhibition of cell growth. The inhibitory effect of IFN is probably not due to a direct competition with ITS. IFN may affect related but not identical cellular pathways as ITS.
In conclusion, we have demonstrated IFN inhibits growth of a colon cancer cell line, in part, by interfering with the ability of ITS to induce growth. Study of the IFN induced regulation of cellular response to insulin and transferrin will provide further insight into the mechanisms of IFN inhibition of cell growth. onr)r
